Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Ojo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BBA Clinical|September 8, 2017
Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancerDiane Ojo, Maryam Seliman, Damu Tang
Cancer Letters|February 11, 2014
PKM2 contributes to cancer metabolismNicholas Wong, Diane Ojo, Judy Yan, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancerDiane Ojo, Ying Wu, Anita Bane, et al.
Cancers|November 24, 2015
Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate CancerDiane Ojo, Xiaozeng Lin, Nicholas Wong, et al.
Scientific Reports|May 1, 2019
Downregulation of CYB5D2 is associated with breast cancer progressionDiane Ojo, David Rodriguez, Fengxiang Wei, et al.
Biomolecules|December 4, 2015
A Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage ResponseXiaozeng Lin, Diane Ojo, Fengxiang Wei, et al.
Cancer Letters|April 8, 2018
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancerDiane Ojo, Xiaozeng Lin, Ying Wu, et al.
Cancer Investigation|June 3, 2014
Changes in PKM2 associate with prostate cancer progressionNicholas Wong, Judy Yan, Diane Ojo, et al.
Current Medicinal Chemistry|April 18, 2015
Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell ExpansionDiane Ojo, Fengxiang Wei, Yun Liu, et al.
Data in Brief|March 4, 2016
Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycleYanyun Xie, Yen Ting Shen, Anil Kapoor, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BBA Clinical|September 8, 2017
Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancerDiane Ojo, Maryam Seliman, Damu Tang
Cancer Letters|February 11, 2014
PKM2 contributes to cancer metabolismNicholas Wong, Diane Ojo, Judy Yan, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancerDiane Ojo, Ying Wu, Anita Bane, et al.
Cancers|November 24, 2015
Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate CancerDiane Ojo, Xiaozeng Lin, Nicholas Wong, et al.
Scientific Reports|May 1, 2019
Downregulation of CYB5D2 is associated with breast cancer progressionDiane Ojo, David Rodriguez, Fengxiang Wei, et al.
Biomolecules|December 4, 2015
A Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage ResponseXiaozeng Lin, Diane Ojo, Fengxiang Wei, et al.
Cancer Letters|April 8, 2018
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancerDiane Ojo, Xiaozeng Lin, Ying Wu, et al.
Cancer Investigation|June 3, 2014
Changes in PKM2 associate with prostate cancer progressionNicholas Wong, Judy Yan, Diane Ojo, et al.
Current Medicinal Chemistry|April 18, 2015
Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell ExpansionDiane Ojo, Fengxiang Wei, Yun Liu, et al.
Data in Brief|March 4, 2016
Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycleYanyun Xie, Yen Ting Shen, Anil Kapoor, et al.
Pageof 2